TY - JOUR
T1 - Influence of cigarette smoking on histological subtypes of stage i lung adenocarcinoma
AU - Maeda, Ryo
AU - Ishii, Genichiro
AU - Yoshida, Junji
AU - Hishida, Tomoyuki
AU - Nishimura, Mitsuyo
AU - Nagai, Kanji
N1 - Funding Information:
Supported, in part, by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor and Welfare, Japan.
PY - 2011/4
Y1 - 2011/4
N2 - Background: The purpose of this study was to examine the association between cigarette smoking and histological subtypes of lung adenocarcinoma. Methods: We reviewed a total of 320 consecutive patients with stage I adenocarcinoma who underwent complete resections with systematic node dissections from January 2004 to December 2006 at the National Cancer Center Hospital East. Results: A statistically significant difference was observed in recurrence-free probabilities between never smokers and ever smokers (3-year recurrence-free probabilities of 95.6% and 88.6%, respectively, p = 0.034). Among adenocarcinoma histological subtypes, only a solid component was significantly more frequent in ever smokers than in never smokers (p < 0.001). Among patients with solid components, significantly more cases had lymphatic permeation (p = 0.007), intratumoral vascular invasion (p < 0.001), and visceral pleural invasion (p < 0.001). Multivariate analysis revealed that ever-smoking history was the only statistically significant independent clinical predictor for a solid component (p < 0.001). Among ever smokers, smoking extent in pack-years of patients with solid components was significantly greater than that of those without solid components (p < 0.001). With respect to predominant subtypes, smoking extent in pack-years of patients with predominantly solid adenocarcinomas was significantly greater than that of patients with predominantly bronchioloalveolar carcinoma, papillary, or acinar adenocarcinomas (all p < 0.001). Conclusion: A greater smoking extent was associated with the presence of adenocarcinoma solid components, which may have more aggressive biological features resulting in poorer outcomes.
AB - Background: The purpose of this study was to examine the association between cigarette smoking and histological subtypes of lung adenocarcinoma. Methods: We reviewed a total of 320 consecutive patients with stage I adenocarcinoma who underwent complete resections with systematic node dissections from January 2004 to December 2006 at the National Cancer Center Hospital East. Results: A statistically significant difference was observed in recurrence-free probabilities between never smokers and ever smokers (3-year recurrence-free probabilities of 95.6% and 88.6%, respectively, p = 0.034). Among adenocarcinoma histological subtypes, only a solid component was significantly more frequent in ever smokers than in never smokers (p < 0.001). Among patients with solid components, significantly more cases had lymphatic permeation (p = 0.007), intratumoral vascular invasion (p < 0.001), and visceral pleural invasion (p < 0.001). Multivariate analysis revealed that ever-smoking history was the only statistically significant independent clinical predictor for a solid component (p < 0.001). Among ever smokers, smoking extent in pack-years of patients with solid components was significantly greater than that of those without solid components (p < 0.001). With respect to predominant subtypes, smoking extent in pack-years of patients with predominantly solid adenocarcinomas was significantly greater than that of patients with predominantly bronchioloalveolar carcinoma, papillary, or acinar adenocarcinomas (all p < 0.001). Conclusion: A greater smoking extent was associated with the presence of adenocarcinoma solid components, which may have more aggressive biological features resulting in poorer outcomes.
KW - Adenocarcinoma
KW - Cigarette smoking
KW - Lung cancer
KW - Solid component
KW - Subtype
KW - Thoracic surgery
UR - http://www.scopus.com/inward/record.url?scp=79953024958&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79953024958&partnerID=8YFLogxK
U2 - 10.1097/JTO.0b013e3182103714
DO - 10.1097/JTO.0b013e3182103714
M3 - Article
C2 - 21325977
AN - SCOPUS:79953024958
SN - 1556-0864
VL - 6
SP - 743
EP - 750
JO - Journal of Thoracic Oncology
JF - Journal of Thoracic Oncology
IS - 4
ER -